Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome, ladies and gentlemen, to the first quarter 2026 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded, and the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain poor-looking statements that are based on current expectations of management and involve inherent risks and uncertainties that could cause actual results that differ materially from those indicated. including the risks and uncertainties described in this company's filings with the Securities and Exchange Commission, including item 1A, risk factors, of the company's most recent annual report and its subsequently filed quarterly reports. You are cautioned not to place undue reliance upon any poor-looking statements which speak only as of the date made. Although it may voluntarily do so from time to time, the company undertakes no commitment to update or revise the poor-looking statements, whether as a result of new information, future events, or otherwise. except as required by applicable securities laws. This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the investor relations portion of our website. I would now like to turn the call over to Mr. Gary S. Goheny Sr. Organogenesis Holdings President, Chief Executive Officer, an...